A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole
Condition(s):Candidiasis, Invasive; CandidemiaLast Updated:March 17, 2023Recruiting